THE CHALLENGES RELATED TO THE RESEARCH

    Scientists doing research into the unravelling and treatment of Usher Syndrome are studying the underlying effect of the mutation and this is not dependent on the Usher Syndrome type. In this way, a strategy for a certain mutation can also be the solution for a similar mutation of another Usher gene type. In their studies the researchers and geneticists use the gene name, whereas physicians use the protein name in their clinical studies. In public databases the gene name is always used.

    STATE OF THE ART FOR EACH USHER GENE

    At this moment, 10 different Usher Syndrome genes are known, all of which are involved in the production of an Usher protein. The various genes are divided into three clinical types, being USH 1, USH 2 and USH 3.  The specific genes are indicated by letters (A, B, C, etc.). Apart from the state of the art for each strategy and methodology, we also have an overview of the research statuses for each Usher gene.


    NATURAL HISTORY STUDIES

    The detailed mapping out of the natural history of the functioning of eyesight and hearing in the different types of Usher Syndrome is essential in order to be able to determine the effectiveness of future therapy. Only after studies have demonstrated the effectiveness and safety of certain therapy types, these will be made available to patients on a large scale after a long process of market implementation.


    GENE THERAPY

    Gene therapy is a treatment method for hereditary disorders in which healthy copies of genes in which faults (= mutations) were found with patients are replaced or added to cells. The replacement genes produce again the proteins that as a result of the mutations were no longer produced. This is meant to stop the deterioration of the functioning of the retina or cochlea. 

    RNA THERAPY

    In RNA therapy the fault as a result of mutations in the DNA at RNA level is repaired by placing a sort of ‘genetic patch’ of antisense oligonucleotides over the fault. As a result of this, the RNA string can be read and translated well, like a zipper that is no longer stuck, and a functional protein can eventually be produced.

    MEDICINES

    Various studies are being conducted into medicines for treating Usher Syndrome. Existing medicines that are already applied to other diseases may possibly also slow down the deterioration process of ears and eyes in connection with Usher Syndrome.

    STEM CELL THERAPY

    Stem cells are unripe cells that can divide but also specialise into specific cells for other tissues. Stem cells can develop into virtually every cell type in the body, which makes them versatile.

    ROD-CONE THERAPY

    Rod-cone therapy is independent of the gene and focused on treating the rods in the eye while keeping the cones intact. The rods of the retina die first (see light and dark).

    INNOVATIONS AND (MEDICAL) AIDS

    Also investigations and studies are conducted in the world that do not specifically offer a solution for people suffering from Usher Syndrome, but that may be of significance for them in the future. Solutions, therapies and medical aids for other disorders can in a later stage be applied to people suffering from Usher Syndrome as well.



    PSYCHO-SOCIAL STUDY

    Usher Syndrome has major psycho-social consequences. The progression of the deterioration of two senses forms an ultimate challenge for the adaptability of people. Professor Claes Möller from Sweden has done a lot of research into the life strategies of people suffering from Usher Syndrome, the psycho-social consequences and their well-being.

    PUBLISHED ARTICLES

    Most scientific studies and trials are published on the following Internet sites:




    IT’S IN THE PROTEINS

    The proteins control all processes in our bodies. These proteins are built using codes that have been captured in the DNA. Due to a writing error in the DNA a protein can be produced incorrectly or not at all. Fixing this DNA error changes the production of the protein and so makes the disorder disappear or reduces the symptoms. This is the idea behind the genetic therapies that are now under development throughout the world.

    ProQR announces first results from STELLAR

    Summary of Phase 1/2 Interim Analysis of QR-421a for Usher Syndrome Program A first-in-human clinical trial of QR-421a is ongoing. The Phase 1/2 study, named Stellar, includes adults that experience […]

    A tailor-made genetic patch for very rare mutations

    New centre for RNA therapy set up for small patient groups. Scientists and physicians of the Leiden University Medical Centre (LUMC) and the Radboudumc together started the Dutch Center for […]

    Development of gene therapy for large USH2C gene

    Patient and researcher form a tandem in scientific research into Usher Syndrome Usher Syndrome patients and researchers of Radboudumc set the tandem in motion again for scientific research into a […]